Supine Percutaneous Nephrolithotomy

July 13, 2022 updated by: Ahmed Maher Gamil Ahmed Higazy, Ain Shams University

Supine Versus Prone Percutaneous Nephrolithotomy in the Pediatric Age Group? A Randomized Controlled Trial.

there is an increased incidence of renal stones, especially in the pediatric age group. the percutaneous approach in the pediatric age took a long time till it again accepted among surgeons worldwide. the prone position is the preferred approach to perform percutaneous nephrolithotomy in the pediatric age group. this study aims to compare supine versus prone position percutaneous nephrolithotomy in the pediatric age group.

Study Overview

Detailed Description

The incidence of renal stones in the pediatric age group increased from 18.4 to 57.0% per100,000 children in the period from 1999 to 2008. The acceptance of PCNL in pediatrics was slow at first due to concerns of the small kidney size compared to relatively large instruments percutaneous nephrolithotomy in pediatric patients was conventionally performed in the prone position for historical reasons, being more familiar to surgeons and it was considered safer to avoid colonic injury.

Supine PCNL has several valuable advantages to pediatric patients in particular better irrigation shorter operative time with a comparable outcome with the prone position.

our study aims to assess the efficacy and the safety of percutaneous nephrolithotomy in the supine position in comparison to the prone position in the pediatric age group.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11367
        • Ain Shams University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients aged from two to sixteen years old with single or multiple renal stones indicated for percutaneous nephrolithotomy

Exclusion Criteria:

  • patients with renal anomalies, bleeding tendency, elevated kidney function tests for age, previous renal surgical intervention on the same site of intervention.
  • patients with skeletal abnormalities and spine deformities were also excluded
  • patients with a single kidney were also excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: supine percutaneous nephrolithotomy
percutaneous nephrolithotomy to be done in the supine position
percutaneous nephrolithotomy to be done in the supine position
Active Comparator: prone percutaneous nephrolithotomy
percutaneous nephrolithotomy to be done in the prone position
percutaneous nephrolithotomy in the prone position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stone free rate
Time Frame: first day postoperative
evaluation of our patients after surgery with Xray or CT to detect residual stones
first day postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluoroscopy time during the procedure in minutes
Time Frame: intraoperative finding in minutes,
time of fluoroscopy exposure in minutes intraoperative, time of radiational exposure during the surgery. operative finding only
intraoperative finding in minutes,
operative time of the procedure in minutes
Time Frame: intraoperative finding in minutes,
time from patient positioning till the end of the procedure, operative finding only
intraoperative finding in minutes,
rate of Hemoglobin drop
Time Frame: day 1 post operative
change in the perioperative hemoglobin level
day 1 post operative
hospital stay
Time Frame: first 2 days post surgery
days of hospital stay after the surgery
first 2 days post surgery
incidence of urinary tract infection
Time Frame: first 7 days post surgery
presence of manifested urinary tract infection in our patient
first 7 days post surgery
urine leakage
Time Frame: first 3 days postoperative
urine leakage from the percutaneous renal tract
first 3 days postoperative
irrigation fluid usage
Time Frame: intraoperative finding
amount of irrigation fluid used during the surgery in liters
intraoperative finding
postoperative fever
Time Frame: first 2 days post surgery
incidence of postoperative fever more than 38 c
first 2 days post surgery
need for DJ application
Time Frame: intraoperative finding
the need for DJ application intraoperative due to rough manipulation, bleeding or residual stones
intraoperative finding
incidence of intraoperative colonic injury
Time Frame: intraoperative finding
the accident injury to adjacent colon
intraoperative finding

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2019

Primary Completion (Actual)

January 1, 2021

Study Completion (Actual)

September 30, 2021

Study Registration Dates

First Submitted

March 6, 2021

First Submitted That Met QC Criteria

April 29, 2021

First Posted (Actual)

May 3, 2021

Study Record Updates

Last Update Posted (Actual)

July 14, 2022

Last Update Submitted That Met QC Criteria

July 13, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Stone

Clinical Trials on percutaneous nephrolithotomy (supine position)

Subscribe